1/ New thread on recently published @CKJsocial paper by @luisloureiro4 using target trial emulation to assess impact of arteriovenous fistula 🩸 formation on kidney function decline 📉
Link 👉 https://t.co/jadEyoAlCe
🧵by @richard_shemilt
🎉 Our first snapshot summary of 2025, this time on sex differences in CKD!
https://t.co/2TvfOQYMN2
Gianmarco Lombardi is the YNP author.
Prepared by @ilayberke.
@ERAkidney@NDTsocial@hjanders_hans
🎄 1/ New thread summarising the recently published @NDTsocial paper by @ynptweets author @richard_shemilt 🏴
Link to paper 👉https://t.co/wijQmZSEcU
🧵by @KaitlinMayne - this one is a particular privilege to feature since it is the work of many @UofGSCMH colleagues🤩
👀 Check our new snapshot summary on fluid removal targets during intermittent renal replacement therapy for AKI!
https://t.co/MdToC3TlsH
@WBeaubien is the YNP author.
Prepared by @smirioglu.
@ERAkidney@CKJsocial
🧵by @PWoywodt
👉What do you know about cosmic kidney disease and have you ever contemplated a flight to Mars 🌃?
👉Space has always fascinated me and as a boy I was very fond of rockets 🚀 so an advance article in the Journal on Cosmic kidney disease intrigued me 🌌
Patients with treatment-resistant hypertension & CKD💊 finerenone showed a ⬇in systolic BP compared to spironolactone (+/- K+ binder) 📉 but had a significantly ⬇ risk of hyperkalemia ⚖️ & fewer treatment discontinuations due to ⬆ potassium levels
https://t.co/g3xiQMD90V
🤩Exciting days ahead for Membranous Nephropathy!
While classic therapies have made strides, 20-30% of cases remain resistant. New agents—from anti-CD20 to CAR T-cell therapy are set to transform MN care with a precision-based approach.
https://t.co/jPTRoLxSAM
@DocL_Floyd
🔥 Our snapshot summary on a survey study on what patients with CKD actually want to know!
https://t.co/WBiS5mHhuB
Jet Milders is the YNP author.
Prepared by @DocL_Floyd.
@ERAkidney@CKJsocial
Long-term outcomes of rituximab-treated adult patients with podocytopathies are largely unknown.
This study found that rituximab facilitated achievement of initial and long-term response in a majority of adult patients with difficult-to-treat podocytopathies.
https://t.co/MOVFbtrBZO
@AKronbichler @audard15 @ClaraGCarro@EllerKathrin @Faguer_S @smirioglu@toomuchaltitude
👩⚕️Being a young doctor is tough - experience takes time. #Mentorship and peer support are key to growth.
🎙️Join us in the 21st episode of our #ERAPodcast series, "#APinchOfSalt"🧂with Orsolya Cseprekál.
🎧 Hit play now 👉 https://t.co/wyBPH2df3I
There are still spots available for our KFL Sunday Lunch - 6th October, 12.30-4pm
Enjoy a delicious lunch and hear from our Chair of Trustees, @afshin6666 who will be talking about Kidneys for Life and our future plans.
https://t.co/suM9gAREAo
The Advanced Nephrology Course is back!
🗓️ 7 - 11 January 2025
📚 Perfect if you're preparing for the ESENeph or need a clinical update.
👥 BIG discounts for UKKA members
🎥 Recordings available
High demand so book now:
🎟️ https://t.co/VT8C4cjstr